It’s never been a tougher time to recruit good quality chemical industry candidates. A recent study of human resources professionals revealed that 92% felt that the UK is experiencing a labour shortage and that this is resulting in significant revenue losses.
Few organisations have avoided the negative implications associated with the challenging economic environment in 2022. Just as Covid-19 and Brexit-related hurdles had been addressed, rising production costs have led manufacturers to take action to stem potential losses.
Market disruptions created by the Covid-19 crisis have primed every aspect of the pharma industry for change. The innovation, collaboration and productivity the world experienced due to the scope and urgency of this crisis were remarkable, and the pharmaceutical industry will never be the same.
Global pollution trends are of big concern for environmental research laboratories; however, certain environmental issues receive less attention than others. While much of the current focus centres on carbon emissions, for example, the role of the global nitrogen cycle in the planet’s ecological processes cannot be underestimated.
The Artificial Intelligence market was valued at $68.1bn in 2021 and is expected to grow at 14.8% CAGR during the period 2021-2026. Growing popularity of the metaverse and its integration with AI is expected to bode well for growth over the period. Furthermore, increasing adoption of explainable AI (XAI) technique, in banking, financial services and insurance (BFSI), retail, e-commerce and advances in quantum computing is also expected to favour growth.
For centuries, chemical innovations have advanced every sector of the economy. But novel chemicals may introduce a degree of risk that must be carefully managed. In Sphera’s 2022 Safety Report, we highlight the trends and developments in process safety management (PSM) and operational risk management (ORM) that have implications for chemical management.
From life-improving medical advancements to technologies that reduce our carbon footprint, our vibrant and diverse science industries are creating the jobs of tomorrow and have the potential to change our world. Yet delivering this level of transformation and innovation while remaining competitive on the global stage is only possible through the support of a highly talented scientific workforce, proficient in the necessary technical skills.
Regulation may be slowing the march to digitalisation for some pharma companies, but the most innovative and forward-looking are proactively engaging with regulatory agencies, boldly moving forward and using advanced technologies that drive a raft of benefits for their own businesses and for the broader community.
The UK ranks third in the world for published scientific research, with nearly 200,000 citable publications in 2020 alone. Unfortunately, however, the UK is rarely the country to make the highest commercial return from its discoveries.
Thousands of litres of chemicals are used each day across these facilities. Inaccurate dosing can cost an operator tens of thousands of Euros in wastage and fines — not to mention irreparable damage to the environment and their reputation.